These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23325325)

  • 61. 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration.
    Brambilla P; Stanley JA; Sassi RB; Nicoletti MA; Mallinger AG; Keshavan MS; Soares JC
    Neuropsychopharmacology; 2004 Oct; 29(10):1918-24. PubMed ID: 15257303
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
    Théberge J; Al-Semaan Y; Drost DJ; Malla AK; Neufeld RW; Bartha R; Manchanda R; Menon R; Densmore M; Schaefer B; Williamson PC
    Psychiatry Res; 2004 Jul; 131(2):107-14. PubMed ID: 15313517
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Proton magnetic resonance spectroscopy and diffusion tensor imaging study of first-episode patients with positive symptoms of schizophrenia].
    Jia YB; Wang Y; Ling XY; Zhong SM; Huang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):374-8. PubMed ID: 22445987
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia.
    Yamasue H; Fukui T; Fukuda R; Yamada H; Yamasaki S; Kuroki N; Abe O; Kasai K; Tsujii K; Iwanami A; Aoki S; Ohtomo K; Kato N; Kato T
    Neuroreport; 2002 Nov; 13(16):2133-7. PubMed ID: 12438941
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Correlations of ADHD symptoms with neurometabolites measured by 1H magnetic resonance spectroscopy.
    Husarova V; Bittsansky M; Ondrejka I; Dobrota D
    Bratisl Lek Listy; 2014; 115(10):635-42. PubMed ID: 25573731
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.
    Bertolino A; Nawroz S; Mattay VS; Barnett AS; Duyn JH; Moonen CT; Frank JA; Tedeschi G; Weinberger DR
    Am J Psychiatry; 1996 Dec; 153(12):1554-63. PubMed ID: 8942451
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Asperger syndrome: a proton magnetic resonance spectroscopy study of brain.
    Murphy DG; Critchley HD; Schmitz N; McAlonan G; Van Amelsvoort T; Robertson D; Daly E; Rowe A; Russell A; Simmons A; Murphy KC; Howlin P
    Arch Gen Psychiatry; 2002 Oct; 59(10):885-91. PubMed ID: 12365875
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Variation of the choline signal intensity in the dorsolateral prefrontal cortex of rats exposed to the forced swimming test as detected by in vivo 1H MR spectroscopy.
    Hong ST; Choi CB; Park C; Hong KS; Cheong C; Jeon YW; Choe BY
    J Neurosci Methods; 2007 Sep; 165(1):89-94. PubMed ID: 17606300
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study.
    Block W; Bayer TA; Tepest R; Träber F; Rietschel M; Müller DJ; Schulze TG; Honer WG; Maier W; Schild HH; Falkai P
    Neurosci Lett; 2000 Aug; 289(2):147-51. PubMed ID: 10904141
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
    He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
    Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study.
    DelBello MP; Cecil KM; Adler CM; Daniels JP; Strakowski SM
    Neuropsychopharmacology; 2006 Jun; 31(6):1264-73. PubMed ID: 16292323
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.
    Reneman L; Majoie CB; Flick H; den Heeten GJ
    AJNR Am J Neuroradiol; 2002 Feb; 23(2):231-7. PubMed ID: 11847047
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differences in brain metabolism associated with agitation and depression in Alzheimer's disease.
    Tsai CF; Hung CW; Lirng JF; Wang SJ; Fuh JL
    East Asian Arch Psychiatry; 2013 Sep; 23(3):86-90. PubMed ID: 24088401
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Proton MR spectroscopy: higher right anterior cingulate N-acetylaspartate/choline ratio in Asperger syndrome compared with healthy controls.
    Oner O; Devrimci-Ozguven H; Oktem F; Yagmurlu B; Baskak B; Munir KM
    AJNR Am J Neuroradiol; 2007 Sep; 28(8):1494-8. PubMed ID: 17846198
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A proton magnetic resonance spectroscopy study in schizoaffective disorder: comparison of bipolar disorder and schizophrenia.
    Kalaycı D; Ozdel O; Sözeri-Varma G; Kıroğlu Y; Tümkaya S
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):176-81. PubMed ID: 22306485
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
    Jessen F; Scherk H; Träber F; Theyson S; Berning J; Tepest R; Falkai P; Schild HH; Maier W; Wagner M; Block W
    Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype.
    Callicott JH; Egan MF; Bertolino A; Mattay VS; Langheim FJ; Frank JA; Weinberger DR
    Biol Psychiatry; 1998 Nov; 44(10):941-50. PubMed ID: 9821558
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proton magnetic resonance spectroscopy (H-MRS) in chronic schizophrenia. A single-voxel study in three regions involved in a pathogenetic theory.
    Granata F; Pandolfo G; Vinci S; Alafaci C; Settineri N; Morabito R; Pitrone A; Longo M
    Neuroradiol J; 2013 Jun; 26(3):277-83. PubMed ID: 23859282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.